The leukemia mortality rate in Japan is forecasted to remain relatively stable between 2024 and 2028, fluctuating slightly from 6.2 to 6.1 male deaths per 100,000 men. In 2023, the rate was also likely around these numbers, indicating minimal variation in mortality rates. Given the consistent figures, the compound annual growth rate (CAGR) over the forecasted period suggests negligible change.
Future trends to watch for include advancements in early detection and treatment technologies, potential shifts in healthcare policies, and public health initiatives that could further reduce mortality rates over the long term.
